Table 1.
Demographic and clinical characteristics
| n | % | |
|---|---|---|
| Total | 54 | 100 |
| COVID-19 testing | ||
| Molecular PCR test | 46 | 85.2 |
| Chest CT | 11 | 20.4 |
| Serology (antibody test) | 16 | 29.6 |
| COVID-19 dedicated treatment | ||
| Oral corticosteroids | 6 | 11.1 |
| Nasal corticosteroids | 4 | 7.4 |
| Inhaled corticosteroids | 2 | 3.7 |
| Azithromycin alone | 7 | 13.0 |
| Hydroxychloroquine alone | 1 | 1.9 |
| Azithromycin + Hydroxychloroquine | 3 | 5.5 |
| Amoxicillin alone | 1 | 1.9 |
| Amoxicillin + Azithromycin | 2 | 3.7 |
| Others (vitamins, zinc) | 5 | 9.3 |
| Self-reported olfactory disorders | ||
| Hyposmia | 4 | 7.4 |
| Anosmia | 49 | 90.7 |
| Parosmia | 11 | 20.4 |
| Phantosmia | 13 | 24.1 |
| Taste disorders | 49 | 90.7 |
| Retro-olfaction alone | 35 | 64.8 |
| Retro-olfaction + taste | 12 | 22.2 |
| Taste alone | 1 | 1.8 |
CT computerized tomography, PCR polymerase chain reaction